ME agenda

Myalgic Encephalomyelitis | political issues | information | commentary | for the UK ME patient community

Archive for the ‘MRC’ Category

Minutes of the MRC CFS/ME Expert Group 2nd meeting: 30 March 2009

Posted by meagenda on November 27, 2009

Minutes of the MRC CFS/ME Expert Group 2nd meeting held on 30 March 2009

WordPress Shortlink for this post: http://wp.me/p5foE-2qT

Open PDF file here:   Minutes of MRC CFSME Expert Group 2nd meeting – 30th March 2009

This locked PDF is also available on the MRC website at:

http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC006522

TEXT version

MRC CFS/ME Expert Group

Minutes of the 2nd meeting held on 30th March 2009

MRC Head Office, 20 Park Crescent, London W1B 1AL

In attendance:

Professor Stephen Holgate (University of Southampton – Chairman)
Professor Philip Cowen (University of Oxford)
Dr Esther Crawley (University of Bristol)
Professor Malcolm Jackson (University of Liverpool)
Dr Jonathan Kerr (St George’s University of London)
Professor lan Kimber (University of Manchester)
Professor Hugh Perry (University of Southampton)
Dr Derek Pheby (National CFS/ME Observatory)
Professor Anthony Pinching (Peninsula Medical School)
Dr Charles Shepherd (ME Association)
Sir Peter Spencer (Action for ME)

MRC
Dr Rob Buckle
Dr Joanna Latimer (Secretariat)

1. Chairman’s welcome, introduction & apologies

1.1 The Chairman welcomed members to the second meeting of the Group and thanked everyone for giving up their valuable time to attend. Introductions were made round the table.

1.2 Apologies had been received from Professor Jill Belch (University of Dundee) and Professor Peter White (Bart’s and the London School of Medicine and Dentistry).

2. Minutes of the 1st Meeting held on 15th December 2008

2.1 Members approved the minutes from the previous meeting as an accurate record, though agreed that an addendum be included that outlined the work of the CFS/ME Clinical and Research Network Collaborative as well as the work of the National Observatory.

3. Terms of Reference

3.1 The Chairman referred members to the revised draft Terms of Reference. Following discussions, the Group agreed that the Terms of Reference needed to incorporate encouragement of new researchers into the field. It was agreed that revised Terms of Reference would be circulated to members for final approval.

4. Update on work of CFS/ME charities

4.1 Sir Peter Spencer and Dr Charles Shepherd updated the Group on progress with the feasibility study for a Post-Mortem Tissue Bank for CFS/ME.

4.2 It was agreed that determining a good clinical phenotype would be key for the success of the proposed bank. This could be aided through setting up longitudinal and natural history studies in addition to a tissue archive. This would be an important area for discussion for the workshop.

5. Discussion on a CFS/ME research workshop

5.1 The Group discussed the format for the research workshop. It was agreed that this would be a small working event attended by CFS/ME researchers, researchers from outside the field and representatives from charities involved in research.

5.2 An overview of current research should be included, and this would be best achieved by providing the participants with a literature review. A two day meeting, from lunchtime to lunchtime, would allow sufficient time for an overview of research in key thematic areas to be presented through short talks, followed by a second day of discussions by small groups tasked with identifying research priorities.

5.3 An integrative approach would be important in helping to understand the causes of CFS/ME, and this should be reflected in the thematic areas highlighted for the short talks. Thefollowing areas were identified for these presentations:

. phenotyping and epidemiology
. autonomic dysfunction including cardiovascular dysfunction
. fatigue
. sleep
. pain
. neuropsychology
. imaging
. new technologies and technological platforms
. neuroendocrinology
. immune dysregulation
. infection

5.4 It would be important to try and bring in leading experts in the above areas from outside of the CFS/ME field, and ideally some of the talks should be presented by such experts. Opening the workshop  up to researchers from other fields should provide an opportunity for new expertise to be bought in and could, in time, lead to increased engagement from the outside community.

5.5 Areas for consideration by the discussion groups on the second day of the workshop should include the following questions:

. how can capacity in the field be increased?
. where are the UK strengths, in the context of international competition, and how could relevant links be forged?
. are there new technologies and/or technological platforms that could help move the field forward?

6. Date of next meeting

Members agreed that the next meeting should be held following the workshop. The secretariat would circulate potential dates in due course.

7. Close

The Chairman thanked members once again for their valuable contributions and closed the meeting.

Posted in AfME, Action for M.E., CFS Research, Freedom of Information, ME Association, ME Research, MRC, Prof Holgate, Professor Peter White | Comments Off

Participant List: MRC CFS/ME Research Workshop

Posted by meagenda on November 23, 2009

Received, today, from MRC Corporate Information and Policy under FOI:

Shortlink: http://wp.me/p5foE-2q2

PDF: participant list November 2009 (2)

23 November 2009

Please find attached a copy of the participants list for the workshop, as promised. This is also available on the MRC website at:

http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC006510

Yours sincerely

Rosa Parker

Rosa Parker | Corporate Information and Policy

Medical Research Council

20 Park Crescent

London

W1B 1AL

———————

Ed: Please note that this list has been amended since this posting was first published as it contained transcription errors. If you have reposted the earlier version of this list, elsewhere, please replace with this  corrected version.

MRC CFS/ME Research Workshop

19th and 20th November 2009

Participant list

Dr Neil Abbot – ME Research UK

Professor Jangu Banatvala – King’s College London

Dr Kate Bishop – National Institute for Medical Research

Dr Gijs Bleijenberg – Radbound University

Professor Tim Cawston – University of Newcastle

Professor Trudie Chalder – King’s College London

Dr Charlotte Clark – Barts and the London

Professor Philip Cowen – University of Oxford

Dr Esther Crawley – University of Bristol

Professor Maria Fitzgerald – University College London

Dr Suzanne Hagan – Glasgow Caledonian University

Dr Kirstie Haywood – University of Warwick

Professor Stephen Holgate – University of Southampton

Professor Jim Horne – University of Loughborough

Dr Jonathan Kerr – St George’s University of London

Professor Paul Little – University of Southampton

Dr Samuele Marcora – Bangor University

Professor Chris Mathias – Imperial College London

Professor Paul Moss – University of Birmingham

Professor Rona Moss-Morris – University of Southampton

Dr Luis Nacul – London School of Hygiene and Tropical Medicine

Professor Julia Newton – University of Newcastle

Dr Derek Pheby – ME Observatory

Professor Anthony Pinching – Peninsula Medical School

Professor Chris Ponting - MRC Functional Genomics Unit

Professor Alan Rickinson – University of Birmingham

Dr Charles Shepherd – ME Association

Dr Vance Spence – ME Research UK

Sir Peter Spencer – Action for ME

Dr Jonathan Stoye – National Institute for Medical Research

Professor Chris Ward – University of Nottingham

Professor Peter White – Barts and the London

Mary-Jane Willow  – Association of Young People with ME

MRC Head office Staff

Dr Rob Buckle
Dr Jo Latimer

http://www.mrc.ac.uk/Ourresearch/ResearchFocus/CFSME/index.htm

MRC CFS/ME Research Workshop

The MRC held a small research workshop for CFS/ME on the 19 and 20th November 2009. The agenda, papers and meeting participants can be found at the links below

Agenda: MRC CFS/ME Research Workshop
http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC006511

List of participants of the MRC CFS/ME Research Workshop
http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC006510

[Open PDF at top of post]

[PDF Format]   Open here: CFSME Literature Review Jan 2004 – Jun 2009[1]   [3MB]

Papers circulated prior to the meeting:

CFS/ME Literature review Jan 2004 – June 2009
http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC006509

Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome: Lombardi VC et al. Science. 2009 326:585-9

Note of the Workshop to follow

—————

[Ed: Note this is an unofficial note of the procedings prepared by Dr Charles Shepherd MEA, not the official MRC note of the Workshop.]

MRC Expert Group on ME/CFS: Brief Notes on Research Workshop held on 19/20 November 2009

Monday, 23 November 2009 16:42

The Medical Research Council’s Expert Group Workshop on ME/CFS Research took place on Thursday 19 November and Friday 20 November at Heythrop Park, Oxford. Around 30 researchers and clinicians from various disciplines, plus MRC staff, took part.

Besides those with existing expertise in this area, there were others present who were new to the subject and consequently brought fresh thinking to the issues and questions being discussed.

PRESENTATION SUMMARIES AND SLIDES

The MRC will be publishing summaries and slides from all the main presentations that were given – once this information has been checked and approved by those who gave the presentations.

I understand that the MRC will also be publishing a full list of everyone who attended this meeting.

The MEA website will carry a suitable link in our news box when all this information appears on the MRC website.

PRESENTATIONS

There were presentations followed by discussions on the following key topics on the first day:

Epidemiology and clinical phenotyping – Dr Esther Crawley
Autonomic dysfunction – Professor Julia Newton
Sleep – Professor Jim Horne
Pain – Professor Maria Fitzgerald
Neuropsychology – Professor Gijs Bleijenberg
Neuroimaging – Professor Phil Cowen
New technologies – Professor Chris Ponting
Immune system dysregulation and infection – Professor Tony Pinching
Virology – Professor Paul Moss

Although not covered by specific presentations, a number of other topics – including muscle abnormalities, mitochondrial dysfunction, post-mortem and tissue bank research – were referred to, along with the way in which patients under the ME/CFS umbrella should be defined and selected to take part in research studies.

The second day consisted of group discussions which considered the following topics:

capitalising on current issues and UK strengths in the area of ME/CFS research
the use of new technologies
partnership models
research prioritisation
Each group then reported back to facilitate a whole group discussion.

The meeting closed with a summing up and an explanation of the next steps forward from Professor Stephen Holgate, Chair of the MRC Expert Group.

BACKGROUND INFORMATION

Background information provided by the MRC included a 351-page literature review of the current state of ME/CFS research and paper copies of the XMRV paper from Science.

The MEA provided copies of the latest edition (October 2009) of our guidelines – ME/CFS/PVFS – An Exploration of the Key Clinical Issues -on research, clinical assessment and management.

INFECTION AND XMRV:

There was a great deal of lively discussion relating to all aspects of XMRV infection – ie existing research findings; replication of the preliminary results from research groups both here and abroad; implications for blood donation; possible pathogenicity of the XMRV infection; future research priorities – during the formal sessions, over dinner, and well into the night on Thursday. We were fortunate in having four researchers present who are all involved with taking this research forward and are well aware of what is happening both here and abroad.

It was made clear to all the researchers present who are involved in retroviral work that the MEA Ramsay Research Fund has money available if this is required urgently to help fund any immediate or short term funding requirement. The MEA is also very willing to look at more major grant proposals relating to XMRV.A link to the latest MEA summary on XMRV can be found on the home page of the MEA website and we will be updating this information later in the week. The website also has details of our exchange of correspondence with Sir Liam Donaldson, Chief Medical Officer, on the subject of blood donation.

The All Party Parliamentary Group on ME has XMRV on the agenda when it meets at the House of Commons on Wednesday 2 December. The Rt Hon Mike O’Brien, Minister of State (Health Services) at the Department of Health, will be present to deal with the main item on the agenda: the APPG Inquiry into NHS Services for people with ME/CFS. This meeting is open to the public – more details re time and venue can be found on the MEA website. If you are intending to come to the meeting please check the MEA website the day before because the House of Commons venue can change at short notice. And do allow at least 30 minutes from arriving at the House of Commons to get through security and find directions the right room.

The Countess of Mar’s Forward ME Group also has research on the agenda when they meet on Tuesday 24 November at the House of Lords.

The MRC workshop also discussed other infections, in particular herpes virus infections, that have been implicated in ME/CFS.

AUTONOMIC DYSFUNCTION: PROFESSOR JULIA NEWTON

Professor Julia Newton and her team at the University of Newcastle, who are working on autonomic dysfunction in ME/CFS, have just had a new paper published in the European Journal of Clinical Investigation. The paper describes an interesting practical approach to the management of symptoms relating to orthostatic intolerance. Ref: Sutcliffe K et al. Home orthostatic training in chronic fatigue syndrome – a randomised placebo-controlled feasibility study. EJCI, November 12 2009. If we can obtain an abstract of this EJCI paper it will be placed on the MEA website news box. The MEA Ramsay Research Fund is currently funding another study at the University of Newcastle to examine muscle energy metabolism in ME/CFS patients. More information can be found in the research section of the MEA website.

MRC: NEXT STEP FORWARD

There are a number of ways in which the MRC can help with a research agenda, in addition to providing finance for good new research proposals. So the next step forward in relation to ME/CFS will be for the MRC Expert Group to meet early in 2010 to discuss the content of this research workshop, along with the conclusions and recommendations that were produced during further discussion on defining research strengths and priorities on the second day.

Personal note

On a personal note I would like to add that while I have been extremely critical of the MRC in the past I believe that Professor Stephen Holgate, who is leading this ME/CFS initiative, is genuinely determined to take forward the biomedical research that the patient population, along with many doctors and researchers, believes is so vital if we are going to find effective forms of management for ME/CFS.

Membership of MRC Expert Group on ME/CFS Research

Professor Stephen Holgate (Chairman)
Professor Jill Belch
Professor Philip Cowen
Dr Esther Crawley
Professor Malcolm Jackson
Dr Jonathan Kerr
Professor Ian Kimber
Professor Hugh Perry
Dr Derek Pheby
Professor Anthony Pinching
Dr Charles Shepherd
Sir Peter Spencer
Dr Rob Buckle (MRC)
Dr Joanna Latimer (MRC)
Dr Charles Shepherd
Hon Medical Adviser, ME Association

23 November 2009

Posted in AfME, Action for M.E., CFS Research, Freedom of Information, ME Association, ME Research, ME events, MRC, Prof Holgate, Professor Peter White, XAND, XMRV, XMRV Retrovirus | Comments Off

MRC Research Workshop: Final Agenda

Posted by meagenda on November 19, 2009

MRC Research Workshop: Final Agenda

Shortlink: http://wp.me/p5foE-2pu

As I was in contact with MRC Corporate Information and Policy, today, I requested confirmation of the presenter on “Fatigue” at today’s meeting which had been listed on the Agenda as “tbc”.

I have been advised that it was not possible to secure a speaker for the proposed session on Fatigue, but that an Open Session was added towards the end of the day. 

A final copy of the Agenda was provided for my information. I am advised that this will be published on the MRC website, early next week.

Note that this is the 3rd Agenda that has been issued (on 19 November) and it supercedes the two previous files posted on this site and elsewhere.

Final Agenda provided on 19 November in PDF format: Final Agenda MRC CFS ME Workshop 19- 20 November 2009

Posted in AfME, Action for M.E., CFS Research, Freedom of Information, ME Association, ME Research, ME events, ME in children, MRC, Prof Holgate, Professor Peter White, XMRV, XMRV Retrovirus | Comments Off

MRC: Withholding List of Participants for MRC CFS/ME Research Workshop

Posted by meagenda on November 17, 2009

MRC: Withholding List of Participants for MRC CFS/ME Research Workshop until after the event has taken place

Shortlink: http://wp.me/p5foE-2ph

Further correspondence, today, with MRC Corporate Governance and Policy.

Link back

MRC CFS/ME Workshop: Revised Agenda and response re request for List of Participants: http://wp.me/p5foE-2nu

Declaration of interests for the CFS/ME Expert Group: http://wp.me/p5foE-2nM

To: Rosa Parker, Head Office MRC
Sent: Tuesday, November 17, 2009 1:38 PM
Subject: Re: Freedom of Information Request: CFS/ME multi-disciplinary panel November Conference and Workshop

17 November 2009

Dear Ms Parker,

Thank you for your responses of 11 and 13 November 2009 which included a PDF copy and revised PDF copy of the Agenda for the forthcoming MRC CFS/ME Expert Group Research Workshop due to take place at the end of this week, on 19-20 November.

Thank you also for the provision of other information in response to three further questions that I had raised with you on 6 November 2009.

I have appended the two emails in which this information had been requested.

One request which remains unfulfilled and which had been requested under the Act, on 19 October, is

“2] A list of participants for this event”

Your response (13 November) has been:

“The MRC is intending to publish a list of participants for the workshop on the 19th and 20th November alongside the note of the meeting. This will be published on our website as soon as it is available following the workshop. I will send you a link to this information as soon as it is available.”

I am not satisfied with the decision to withhold the information requested under the Act until some point after the Workshop has taken place.

I am not satisfied that this part of my request for information has been handled properly because no reason(s) has been given for the decision not to provide this information to me under the Act prior to the Workshop taking place.

It is my intention to lodge a formal complaint through the complaints system, for which you have provided various options and contact details.

In order to take this forward, I should be pleased if you would provide the following:

a) An acknowledgement of receipt of this communication.

b) A reference number for my original request for information under FOIA of 19 October 2009.

c) The reason(s) for the decision not to provide this information under the Act at this point in time.

d) The specific clause(s) from the Act under which this decision has been taken.

Sincerely,

etc

[Previous correspondence appended]

Posted in AfME, Action for M.E., CFS Research, Freedom of Information, ME Association, ME Research, MRC, Prof Holgate, Professor Peter White | Comments Off

Declaration of interests for the CFS/ME Expert Group

Posted by meagenda on November 13, 2009

Declaration of interests for the CFS/ME Expert Group

Shortlink: http://wp.me/p5foE-2nM

On 13 November, Tate Mitchell reports, via Co-Cure, a new page on the MRC’s website:

Declaration of interests for the CFS/ME Expert Group

http://www.mrc.ac.uk/Ourresearch/ResearchFocus/CFSME/DoI/index.htm

Interests for members of the Expert Group are declared under the following categories:

Personal Remuneration (employment, pensions, consultancies, directorships, honoraria etc)
Registrable Shareholdings and Financial Interests in Companies
Research Income during current session (over £50k per grant)
Major academic collaborations (national and international)
Unremunerated involvement with and membership of medical, biomedical, pharmaceutical, healthcare provision or similar activities/organisations
Political/pressure group associations
Members are informed of the MRC policy of declarations of interest at the first meeting and asked to return their completed forms to the Secretariat. The interest declared to date are listed below.

Dr Charles Shepherd

Dr Derek Pheby

Dr Esther Crawley

Dr Jonathan Kerr

Professor Anthony Pinching

Professor Hugh Perry

Professor Ian Kimber

Professor Malcolm Jackson

Professor Peter White

Professor Philip Cowen

Professor Stephen Holgate

Sir Peter Spencer

Posted in AfME, Action for M.E., CFS Research, DWP, ME Association, ME Research, MRC, Professor Peter White, XMRV, XMRV Retrovirus | Comments Off

MRC CFS/ME Workshop: Revised Agenda and response re List of Participants

Posted by meagenda on November 13, 2009

MRC CFS/ME Workshop: Revised Agenda and response re request for List of Participants

Shortlink: http://wp.me/p5foE-2nu

I have received, this afternoon, a further response from Ms Rosa Parker, MRC Corporate Information and Policy, in connection with a request for information under FOIA.

See previous posting: http://wp.me/p5foE-2mj

Ms Parker’s response follows.  Note that the MRC is choosing not to release the List of Participants until after the Workshop has taken place.  On Monday, I shall submit an Appeal.

Readers may recall that the List of Participants for the November 2006 AfME/MRC joint Research Summit was obtained by ME agenda under FOI in December 2006.

See: The AfME Research Summit and the list they did not want us to see

Why is the MRC not prepared to release the List of Participants prior to this Workshop?

—————–

Revised Agenda in PDF format: Revised Agenda – MRC CFSME Workshop

The MRC’s response, today, 13 November:

Further to my email of 11 November 2009 I am now able to reply with regard to your request for:

2] A list of participants for this event

The MRC is intending to publish a list of participants for the workshop on the 19th and 20th November alongside the note of the meeting. This will be published on our website as soon as it is available following the workshop. I will send you a link to this information as soon as it is available.

I have also attached a slightly revised copy of the agenda as there was a small typographical error in the version I sent to you on the 11th of November.

I hope that you are satisfied that your request has been handled appropriately. If not, you may appeal using the MRC’s complaints procedure.

Details are on the MRC website at: www.mrc.ac.uk/index/about/about-contact/about-complaints_procedure.htm

alternatively you may contact the MRC Complaints Officer by email at customer.service@headoffice.mrc.ac.uk or write to The Complaints Officer, Medical Research Council, 20 Park Crescent, London W1B 1AL.

If, following the Complaints Officer’s reply, you remain dissatisfied; you may contact the Information Commissioner. Details of how to take your complaint further are at www.informationcommissioner.gov.uk

Yours sincerely,
Rosa Parker

Rosa Parker | Corporate Information and Policy
Medical Research Council
20 Park Crescent
London
W1B 1AL

Posted in AfME, Action for M.E., CFS Research, Freedom of Information, ME Association, ME Research, MRC, Prof Holgate, Professor Peter White, XAND, XMRV, XMRV Retrovirus | Comments Off

Two responses around XMRV: Prof Simon Wessely; Dept of Health

Posted by meagenda on November 12, 2009

Two responses around XMRV: Prof Simon Wessely; Dept of Health

Shortlink: http://wp.me/p5foE-2mS

Two users of the Whittemore Peterson Institute Facebook site have kindly given permission for the following responses to be reproduced here, on ME agenda.

Update: The response from Professor Simon Wessely following an enquiry by a member of the public has been removed since permission for publication and the terms under which Professor Wessely’s response might be republished had not been discussed.  A copy of the response was also published by me via Co-Cure together with the response from the Department of Health.  This is also being removed.

——————-

Whittemore Peterson Institute on Facebook

Heath reported on 12 November that he wrote to the Department of Health.  The DoH response was:

Thank you for your email of 28 October to the Department of Health about xenotropic murine leukemia virus-related virus and chronic fatigue syndrome/myalgic encephalopathy (CFS/ME).

The Department of Health agrees with the World Health Organization’s classification of CFS/ME as a neurological condition of unknown cause. The Department also agrees that CFS/ME is a genuine and disabling illness and can have a profound effect on those living with the condition. That is why research breakthroughs such as the one outlined in your email, are so important to developing the knowledge base.

The National Institute for Health and Clinical Excellence (NICE) clinical guidelines are updated as needed so that recommendations take into account important new evidence. However, as I hope you will appreciate, as NICE is an independent body, the time-frame for revising guidance and the evidence it uses are matters entirely for NICE. You may therefore wish to raise this issue directly with NICE’s Chief Executive, Andrew Dillon, at the following address:

NICE
MidCity Place
71 High Holborn
London WC1V 6NA

I think it also helpful to emphasise that NICE clinical guidelines are just that – guidelines for healthcare professionals use in conjunction with their clinical judgement and based on an individual assessment of each patient’s needs. The guideline recognises that there is no one form of treatment to suit every patient and it does not force patients into treatments they do not want.

The guideline emphasises a collaborative relationship between clinician and patient, that treatment and care should take into account personal needs and preferences, and that healthcare professionals should recognise that the person with CFS/ME is in charge of the aims of the treatment programme.

Cognitive Behavioural Therapy is a rehabilitative approach designed to modify the way patients think and behave about their illness and so improve physical symptoms. In common with other illnesses and conditions where it has been successfully used such as chronic pain, cancer, heart disease and diabetes, its use does not imply that the cause of the illness is psychological.

The Department feels that it is not helpful to differentiate between biomedical and psychosocial treatments as, based on clinical evidence that is currently available, patients are best served by a holistic approach.

You also comment on the paucity of bio-medical research. I know that many of the Department’s stakeholders see biomedical research as the key to developing new treatments and the Department appreciates the concern about a lack of biomedical research in this area.

As you may know, the main agency through which the Government supports medical and clinical research is the Medical Research Council (MRC). The MRC is wholly independent in its choice of which research to support and it does not generally earmark funds for particular topics. It maintains a rigorous decision making process and only funds research that is likely to make a significant contribution to knowledge and is a good use of taxpayers’ money. Decisions to support proposals are taken on the grounds of scientific quality and whether the research proposed would be likely to inform the knowledge base. There is certainly no bias, and the Department knows that the MRC remains committed to funding scientific research in all aspects of CFS/ME.

The Department understands that the MRC continues to attract a small number of proposals for biomedical research. The problem is that there appears to be a shortage of good and innovative ideas within the scientific community itself. This is something the Department knows that the CFS/ME community and the MRC are aware of, and the MRC have endeavoured to address this by engaging with patient groups to encourage high quality research proposals. The MRC continues to acknowledge the importance of research into CFS/ME, and it is difficult to see what more the MRC could do without lowering the quality threshold.

I hope this reply is helpful.

Yours sincerely,

Priya Bassan
Department of Health

Related information:

Source: ME Research UK

http://www.meresearch.org.uk/information/publications/casetoanswer.html

The Medical Research Council: a case to answer?

[...]

CFS/ME projects currently funded by the MRC
(Sources: MRC website; Hansard, written answers)

•Two large clinical trials of new approaches to treating CFS/ME:
          PACE (Pacing, Activity and Cognitive Behaviour Therapy: a Randomised Evaluation, £2,076,363) [Prof. PD White, Psychological Medicine, Queen Mary and Westfield College]
          FINE (Fatigue Intervention by Nurses Evaluation, £824,129) [Dr AJ Wearden, Psychological Science, Uni. of Manchester]

•A preliminary epidemiological project to test the feasibility of identifying the risk factors for persistent symptoms of fatigue and abdominal and widespread pain (£118,263) [Prof. F Creed, Psychological Medicine, University of Manchester]

•An epidemiological study to assess ethnic variations of the prevalence of a CFS-like illness, associations with potential risk factors, and coping behaviours (£162,145) [Prof. K Bhui, Cultural Psychiatry and Epidemiolgy, Queen Mary and Westfield College]

•Indirect support through a trial exploring the management of patients with persistent unexplained symptoms [Specifics unknown]

•One project was mentioned in Hansard (12th June 2008) but is not on the MRC website: General and specific risk markers and preventive factors for chronic fatigue and irritable bowel syndromes (£367,000) [Dr C Clark, Centre for Psychiatry, Barts and The London School of Medicine]

 

Table. Unfunded applications to the MRC between 2002 and 2008

Time-frame   (number of applications)   CFS/ME subject area

2002 to 2005 (11 total) Neurophysiology of fatigue; Population-based/epidemiological studies (4 applications); Neurotransmitters and stress; Neuroimaging; Clinical and laboratory characterisation physiology/diagnosis); Dietary intervention — RCT; Facilitated self-help — RCT; Psychosocial and genetic factors in young people

2005 to 2006 (12 total) Pathophysiology, including studies regarding genetics/biomarkers, immunology and neuroimaging (7 applications); Population-based/epidemiological studies (3); Primary care study; Experimental medicine study

2006 to April 2007 (7 total) Cognitive outcomes in children — pathophysiology; Epidemiological studies — epidemiology; Biomarkers; Pathophysiology (2 applications); Molecular pathogenesis — pathophysiology; Molecular and genetic characterisation — pathophysiology; Neuroimaging — pathophysiology

May 2007 to June 2008 (3 total) Biomarkers — pathophysiology; Management and treatment — intervention; Management and treatment — observational study

Posted in CBT, CBT/GET, CFS Research, CFS in the media, Canadian Criteria, DoH, FINE Trial, ME Research, ME Research UK, ME in journals, MRC, NICE CFS/ME guideline, Prof Holgate, Professor Peter White, Simon Wessely, WHO (World Health Organization), XMRV, XMRV Retrovirus | Comments Off

CMO response to ME Association letter around XMRV and Blood Donation

Posted by meagenda on November 12, 2009

CMO response to ME Association letter around XMRV and Blood Donation

Shortlink: http://wp.me/p5foE-2mM

The MEA published the following statement today:

MAY BE REPOSTED

The ME Association wrote to Sir Liam Donaldson, Chief Medical Officer at the Department of Health, in October in relation to XMRV research – in particular the situation regarding blood donation and blood transfusion services here in the UK.

A copy of this letter is available in the October news archive on the MEA website: http://www.meassociation.org.uk

We have now received a reply from the CMO, with the following key points:

  The Standing Advisory Committee on Transfusion Transmitted Infections (SACTTI), part of UK Blood Services, will be producing a risk assessment for this virus.

  The current advice from UK Blood Services in relation to ME/CFS has been further clarified: Individuals suffering from ME/CFS are deferred from blood donation until their condition has resolved and they are feeling completely well.

  The research has also been drawn to the attention of the secretariats for the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) and the National Expert Panel on New and Emerging Infections (NEPNEI), who will continue to monitor developments in conjunction with UK Blood Services and the Health Protection Agency.

A copy of the MEA letter and information on XMRV has also been passed to the Professional Director of the UK Blood Services Joint Professional Advisory Committee, along with all the UK virology and retrovirology experts who were copied into our original correspondence.

The MEA would like to thank everyone who has been in contact with information regarding blood donation by people with ME/CFS in other countries. We are keen to continue building up this database and any further help here would be much appreciated. It appears that there are very few countries who currently take the same position, or a similar position on blood donation, to that in the UK.

XMRV research will obviously feature during discussions that will be taking place at the Medical Research Council’s Expert Group Workshop on ME/CFS next week in Oxfordshire.


Dr Charles Shepherd
Hon Medical Adviser, ME Association
Member of the MRC Expert Group

Posted in Blood Donation, CFS Research, CFS in the media, ME Research, ME in journals, MRC, Prof Holgate, XMRV, XMRV Retrovirus | Comments Off

Text of Agenda for November MRC CFS/ME Workshop and AfME response

Posted by meagenda on November 12, 2009

Text of Agenda for MRC CFS/ME Expert Group Research Workshop 19-20 November 2009 and Action for M.E.’s Facebook response

Shortlink: http://wp.me/p5foE-2mD

Below is the text of the Agenda for the November MRC Workshop.  I have posted links for this Agenda and other information provided by the MRC, yesterday, on the Facebook Walls of Action for M.E. and the ME Association.  At the time of writing, neither organisation has published a copy of the Agenda, itself, on its main website.

Since flagging up the Agenda on Action for M.E.’s Facebook site, and some ensuing comments by users of the site, the following has been added by the moderators:

http://www.facebook.com/actionforme

“Sir Peter has asked Professor Holgate to ensure during the course of the two-day event that particular consideration be given to the XMRV findings and current efforts to replicate them by other researchers.”

“Action for M.E. MRC CFS/ME research workshop Sir Peter Spencer, CEO, Action for M.E. and other M.E. charity representatives will attend a multi-disciplinary workshop for researchers, organised by the Medical Research Council (MRC), 19-20 November.”

“The meeting, chaired by Professor Stephen Holgate, MRC Professor of Immunopharmacology from Southampton University, aims to encourage new research into M.E./CFS, harnessing the latest technologies and scientific thinking to develop a proper understanding of the underlying disease mechanisms.

Papers circulated include information about XMRV, the retrovirus identified in 68 out of 101 CFS patients by researchers at the Whittemore Peterson Institute in Reno, USA. Although the sample is small, the results have led to calls for greater investigation into the biology of M.E.

Sir Peter has asked Professor Holgate to ensure during the course of the two-day event that particular consideration be given to these findings and current efforts to replicate them by other researchers.

Anyone who wishes to contact Sir Peter about the workshop may do so by e-mailing consultations@afme.org.uk

“Scientists participating in the MRC workshop are already due to hear short presentations on phenotyping and epidemiology, autonomic dysfunction, fatigue, sleep, pain, neuroimaging, new technologies, immune dysregulation, infection and virology.

There will be an opportunity for group discussion before delegates split up into workshops.

These will consider:
- capitalising on current issues and UK scientific strengths
- new technologies and technological platforms
- national resources eg. patient cohorts
- partnership models
- research prioritisation
- other issues.

Professor Holgate will then summarise the workshop’s discussions, which will indicate a way forward for future work.”

 

Text of Agenda for MRC CFS/ME Research Workshop 19-20 November 2009

Note: I am advised by Ms Parker, MRC Corporate Governance and Policy, that “We are still in discussion with colleagues regarding the participants list and will respond to this part of your request in due course.”  I will post the list of participants when the MRC has fulfilled this part of the FOI request for information.

Also note that the timings, as set out in the document for the afternoon session of Day One, are squiffy. I have reproduced as supplied by the MRC in the PDF.

AGENDA in PDF format here: http://wp.me/p5foE-2mj

——————————

[MRC Logo] Medical Research Council

MRC CFS/ME Research Workshop

To be held on Thursday 19th & Friday 20th November

Location: Hethrop Park Resort (Chipping Norton, Oxfordshire OX7 5UF)

Agenda – Thursday 19th November

13:00 Registration; Lunch
Tea & Coffee
____________________________________________

13:30 Welcome and Introduction by Professor Stephen Holgate

Aims of the Workshop
____________________________________________

Short Presentations:

Topic    Speaker

13:45 CFS/ME phenotyping & epidemiology    Dr Esther Crawley

14:00 Autonomic dysfunction Professor    Julia Newton

14:45 Fatigue    tbc

14:15 Sleep Professor    Jim Horne

14:30 Pain Professor    Maria Fitzgerald

____________________________________________

15:00 Tea & Coffee
____________________________________________

15:30 Neuropsychology    Professor Gijs Bleijenberg

15:45 Neuroimaging    Professor Phil Cowen*

[*Ed: Philip Cowen is Professor of Psychopharmacology and MRC Clinical Scientist at the University of Oxford. His research and clinical interests are in the biochemistry and treatment of mood disorders, and particularly the pharmacological management of resistant depression.]

16:00 New Technologies    Professor Chris Ponting

16:15 Immune dysregulation/Infection    Professor Tony Pinching

16:00 Virology    Professor Paul Moss

____________________________________________

16:45 Tea & Coffee
____________________________________________

17:00-18:00 Group discussion
____________________________________________

19:00 Dinner
____________________________________________

Agenda – Friday 20th November

09:00 Introduction – brief for morning session – Professor Stephen Holgate

09:15 Working group discussions

‘What would you like to see the field respond to?’

Areas for consideration:
. capitalising on current issues and UK scientific strengths
. new technologies and technological platforms
. national resources e.g. patient cohorts
. partnership models
. other issues

______________________________________

10:45 Tea & Coffee
____________________________________________

11:00 Whole group discussion

11:45 Summing up and next steps – Professor Stephen Holgate

12:00 Close
____________________________________________

AGENDA in PDF format here: http://wp.me/p5foE-2mj

Link Back

Agenda: MRC CFS/ME Research Workshop 19-20 November 2009 and additional information provided by the MRC under FOIA:

WordPress Shortlink: http://wp.me/p5foE-2mj

The Agenda and Minutes of the meeting on 15 December can be downloaded here or opened in PDF format here:

PDF: Minutes CFS/ME Expert Group Meeting 15 December 2008

The list of members can be opened in PDF format here:

PDF: CFS/ME Expert group membership

Term of Reference can be opened in PDF format here:

PDF: Finalised Terms of Reference for CFS/ME expert group

or go to MRC site for full article and files:

Chronic Fatigue Syndrome/Myalgic Encephalomyelitis 

( http://www.mrc.ac.uk/Ourresearch/ResearchFocus/CFSME/index.htm )

Posted in AfME, Action for M.E., CFS Research, CFS in the media, Canadian Criteria, ME Association, ME Research, ME events, ME in journals, MRC, Prof Holgate, Professor Peter White, XMRV, XMRV Retrovirus | Comments Off

Agenda: MRC CFS/ME Research Workshop 19-20 November 2009

Posted by meagenda on November 11, 2009

Agenda: MRC CFS/ME Research Workshop 19-20 November 2009

WordPress Shortlink: http://wp.me/p5foE-2mj

I have received the following response, today, from Ms Rosa Parker, Corporate Governance and Policy, Medical Research Council under the FOI Act:

 Workshop AGENDA in PDF format:  Agenda MRC CFS/ME Workshop 19 – 20 November

I had asked for:

1] A copy of the Agenda for this event.

2] A list of participants for this event

3] Clarification of whether the CFS/ME Expert Group intends to continue to hold meetings beyond the Conference / Workshop in November.

Ms Parker’s response:

“The agenda has now been finalised and circulated, a copy is attached. We are still in discussion with colleagues regarding the participants list and will respond to this part of your request in due course. You also asked whether the Expert Group intends to hold any further meetings following the Workshop; I can confirm that the Expert Group does intend to hold a meeting following the workshop. The dates of this meeting have yet to be confirmed, the note of this third meeting will be published on our website in due course.

“You have now also asked a couple of additional questions. You have asked whether a note or report of the workshop will be available. I can confirm that a note of the workshop will be published on our website, but I am not able to confirm the timescale at this stage. You have also asked about the minutes of the second meeting of the Expert Group. The minutes are currently being finalised and as soon as they have been approved they will be made available on our website, at the moment we expect this to be within the next month.”

“I hope that this information is helpful, and I will be in touch regarding the participants list in due course.”

Rosa Parker
Corporate Governance and Policy, Medical Research Council

11 November 2009

Link back

MRC Two day Research Workshop 19 and 20 November 2009

WordPress Shortlink: http://wp.me/p5foE-2bS

The Agenda and Minutes of the meeting on 15 December can be downloaded here or opened in PDF format here:

PDF: Minutes CFS/ME Expert Group Meeting 15 December 2008

Document Library
CFS/ME Expert Group meeting – 15 December 2008
Issued: 15 Dec 2008
Primary audience: Researchers
Document Summary

The list of members can be opened in PDF format here:

PDF: CFS/ME Expert group membership

Term of Reference can be opened in PDF format here:

PDF: Finalised Terms of Reference for CFS/ME expert group

or go to MRC site for full article and files:

Chronic Fatigue Syndrome/Myalgic Encephalomyelitis 

( http://www.mrc.ac.uk/Ourresearch/ResearchFocus/CFSME/index.htm )

Posted in AfME, Action for M.E., CFS Research, Freedom of Information, ME Association, ME Research, MRC, Prof Holgate, Professor Peter White | Comments Off